Search

TransMedics Group Inc

Lezárt

SzektorEgészségügy

84.56 -2.15

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

84.43

Maximum

87.76

Fő mutatók

By Trading Economics

Bevétel

7.4M

15M

Értékesítés

16M

190M

P/E

Szektor átlag

23.311

56.597

Egy részvényre jutó nyereség

0.44

Profit margin

7.729

Munkavállalók

898

EBITDA

-889K

27M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+5.48% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. okt. 28.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

302M

3.1B

Előző nyitás

86.71

Előző zárás

84.56

Hangulat hírek alapján

By Acuity

82%

18%

317 / 339 Rangsor szerint Healthcare

TransMedics Group Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 9. 20:07 UTC

Social Media

Transmedics Group Inc shares are lower today, breaking a recent trend despite positive sentiment reported by Jefferies' Transplant Tracker earlier this month.

2026. szept. 8. 19:56 UTC

News
Social Media

Transmedics Group reported EPS of $0.44 but lowered its adjusted operating margin guidance, contributing to a decline in shares since Friday's close.

2026. szept. 4. 20:07 UTC

News

Transmedics Group reported Q2 EPS of $0.44, missing estimates. The company raised its 2026 revenue outlook, boosting investor sentiment and shares during Friday's session.

2026. szept. 2. 19:56 UTC

Transmedics Group Inc shares are trading higher today, reflecting notable intraday volatility amid rising U.S. Treasury yields and broader market fluctuations.

2026. szept. 1. 20:09 UTC

Transmedics Group Inc shares declined during Tuesday's session, reaching a low before a slight recovery. The stock remains below its 20-day moving average.

2026. aug. 31. 20:03 UTC

Transmedics Group Inc shares are declining amid broader economic concerns following remarks from Warsh at the Jackson Hole Economic Symposium.

2026. aug. 28. 20:07 UTC

Transmedics Group Inc shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and no specific company news identified.

2026. aug. 27. 19:16 UTC

Transmedics Group Inc. shares are lower amid broader market concerns about persistent U.S. inflation, despite a brief midday rebound earlier in the session.

2026. aug. 26. 21:36 UTC

Transmedics Group Inc. shares declined slightly in after-market trading, reflecting broader market caution ahead of Nvidia's earnings report and recent inflation data.

2026. aug. 25. 19:46 UTC

TransMedics Group Inc is trading lower today, with no specific news identified. The stock remains near its one-month range's upper end.

2026. aug. 24. 23:06 UTC

TransMedics Group Inc shares are lower in after-market hours, reflecting a decline since Monday's close. Broader market concerns about the U.S.-Iran conflict persist.

2026. aug. 21. 19:36 UTC

Transmedics Group Inc shares are higher, maintaining an upward trend since Thursday's close despite a pullback from earlier session highs. No specific news identified.

2026. aug. 20. 19:46 UTC

Transmedics Group Inc is trading lower today, following an early drop that set the day's low. No specific news was identified for the decline.

2026. aug. 19. 23:11 UTC

Transmedics Group Inc is trading lower in after-market hours, having retraced from a brief peak earlier in the session amid routine price activity.

2026. aug. 18. 19:16 UTC

Social Media

Transmedics Group plans to accelerate revenue growth, projecting $757 million by 2026. Shares are higher today, rebounding from earlier session lows.

2026. aug. 13. 19:52 UTC

Transmedics Group Inc shares are trading higher, recovering from an earlier low. The stock remains above its 20-day moving average amid strong sector interest.

2026. aug. 12. 19:36 UTC

Transmedics Group Inc shares are lower during Wednesday's session amid unusual volatility. The stock remains above its 20-day moving average despite the decline.

2026. aug. 11. 19:16 UTC

Transmedics Group Inc. shares are lower today, pulling back from an earlier session high. The stock remains above its 20-day moving average.

2026. aug. 10. 19:21 UTC

Social Media

Transmedics Group Inc is rising amid a broader rally in Health Care Equipment. Positive market sentiment and strong performance metrics are driving interest in the stock.

2026. aug. 7. 19:22 UTC

News

TransMedics shares are higher as Piper Sandler and Needham adjust price targets, reflecting positive sentiment from multiple analysts during Friday's trading session.

2026. aug. 6. 20:03 UTC

Social Media
News

Transmedics Group Inc shares are higher, supported by positive Q2 results and mentions in a fund manager's portfolio, despite potential short-term volatility concerns.

2026. aug. 5. 20:03 UTC

Social Media
News

TransMedics Group Inc. shares are lower following mixed quarterly results and an earnings miss, prompting price target cuts from Piper Sandler and UBS.

2026. aug. 4. 23:02 UTC

News
Social Media

Transmedics Group shares are lower in after-market hours following Q2 results, where adjusted EPS of $0.44 missed expectations despite revenue surpassing estimates.

2026. aug. 3. 19:51 UTC

Social Media
News

TransMedics Group Inc. shares are rising, despite an analyst downgrade to a $106 price target from $142, amid positive social media discussions.

2026. júl. 30. 19:03 UTC

Transmedics Group Inc shares are lower during Thursday's session, with no specific news identified. Broader market uncertainty may be influencing the decline.

2026. júl. 29. 23:36 UTC

Transmedics Group Inc. shares are lower in after-market trading, reflecting broader market volatility amid rising interest rates and geopolitical tensions.

2026. júl. 28. 19:46 UTC

Transmedics Group Inc shares are higher today, advancing since Monday. The stock peaked earlier but pulled back from a session high.

2026. júl. 27. 15:16 UTC

Social Media
News

Transmedics Group Inc is higher today amid social media discussions on its undervaluation and expectations for significant profit by 2028.

2026. júl. 24. 20:02 UTC

Social Media

Transmedics Group Inc gains amid positive feedback from Jefferies on its technology and growth prospects, aligning with strength in the Health Care Equipment sector.

2026. júl. 22. 19:46 UTC

Transmedics Group Inc shares are lower today, reflecting ongoing declines. The stock's volatility coincides with rising crude oil prices amid geopolitical tensions.

Társak összehasonlítása

Árváltozás

TransMedics Group Inc Előrejelzés

Célár

By TipRanks

5.48% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 93.11 USD  5.48%

Magas 122 USD

Alacsony 65 USD

11 Wall Street elemző 12 hónapos célárain alapulva a(z)TransMedics Group Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

11 ratings

7

Vétel

4

Tartás

0

Eladás

Hangulat

By Acuity

317 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Nagyon erős bearish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk TransMedics Group Inc

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
help-icon Live chat